Table of Contents
Volume 2 | Issue 3
Publication Date: February 2001- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
170 |
Lung Cancer: A Look Beyond the Present Chandra P. Belani |
|
Meeting Highlights | ||
173-177 |
Highlights From: 25th European Society for Medical Oncology Congress Hamburg, Germany Amy D’Orazio |
|
Researches in Brief | ||
178-179 |
Phase II and Phase III Trials, Docetaxel/Irinotecan versus Docetaxel/Cisplatin in Advanced Non–Small-Cell Lung Cancer (WJTOG 9803) CIG Media Group |
|
180-181 |
Irinotecan/Cisplatin versus Vindesine/Cisplatin versus Irinotecan Alone in Advanced Non–Small-Cell Lung Cancer CIG Media Group |
|
Comprehensive Review | ||
182-190 |
Effectiveness of Radiation Therapy on Non–Small-Cell Lung Cancer Eric L. Gressen, Walter J. Curran, Jr. |
|
Commentaries | ||
191-192 |
Commentary on “Effectiveness of Radiation Therapy on Non–Small-Cell Lung Cancer” James A. Bonner |
|
193-194 |
Commentary on “Effectiveness of Radiation Therapy on Non–Small-Cell Lung Cancer” Nevin Murray, Finbarr Sheehan |
|
Comprehensive Review | ||
197-203 |
Radiosurgery and Radiotherapy for Non–Small-Cell Lung Cancer Metastatic to Brain May N. Tsao, Penny K. Sneed, Michael W. McDermott, David A. Larson |
|
Original Contributions | ||
204-209 |
Carboplatin/Etoposide/Paclitaxel in the Treatment of Patients with Extensive Small-Cell Lung Cancer Harvey B. Niell, Michael C. Perry, Gerald Clamon, Jeffrey Crawford, Antonius A. Miller, James Herndon II, Mark R. Green |
|
210-215 |
Placebo-Controlled Trial of Bexarotene, a Retinoid X Receptor Agonist, as Maintenance Therapy for Patients Treated with Chemotherapy for Advanced Non–Small-Cell Lung Cancer Naiyer Rizvi, Michael J. Hawkins, Peter D. Eisenberg, Richard C. Yocum, Steven D. Reich, and the Ligand L1069-20 Working Group |
|
216-219 |
Effect of HER2/neu Expression on Survival in Non–Small-Cell Lung Cancer Vijaya Korrapati, Maryanne Gaffney, Lisbeth G. Larsson, Lucio Di Nunno, Mark Riggs, Robert S. Beissner, John J. Rinehart, Frank E. Mott |
|
Translational Medicine | ||
220-226 |
Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer Alex W. Tong, Yu-An Zhang, Casey Cunningham, Phillip Maples, John Nemunaitis |
|
Imaging in Lung Cancer | ||
229-233 |
The Role of Positron Emission Tomography in Evaluating Mediastinal Lymph Node Metastases in Non–Small-Cell Lung Cancer James D. Luketich, David M. Friedman, Carolyn C. Meltzer, Chandra P. Belani, David W. Townsend, Neil A. Christie, Tracey L. Weigel |
|